4.8 Article

Mechanisms of translational regulation by a human eIF5-mimic protein

期刊

NUCLEIC ACIDS RESEARCH
卷 39, 期 19, 页码 8314-8328

出版社

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkr339

关键词

-

资金

  1. National Institutes of Health [GM64781]
  2. NCRR [P20 RR016475]
  3. K-state Terry Johnson Cancer Center
  4. NIDCR
  5. BBSRC [BB/E002005/1, BB/H010599/1]
  6. [GM49164]
  7. BBSRC [BB/H010599/1, BB/E002005/1] Funding Source: UKRI
  8. Biotechnology and Biological Sciences Research Council [BB/E002005/1, BB/H010599/1] Funding Source: researchfish
  9. Grants-in-Aid for Scientific Research [22115511] Funding Source: KAKEN

向作者/读者索取更多资源

The translation factor eIF5 is an important partner of eIF2, directly modulating its function in several critical steps. First, eIF5 binds eIF2/GTP/Met-tRNA(i)(Met) ternary complex (TC), promoting its recruitment to 40S ribosomal subunits. Secondly, its GTPase activating function promotes eIF2 dissociation for ribosomal subunit joining. Finally, eIF5 GDP dissociation inhibition (GDI) activity can antagonize eIF2 reactivation by competing with the eIF2 guanine exchange factor (GEF), eIF2B. The C-terminal domain (CTD) of eIF5, a W2-type HEAT domain, mediates its interaction with eIF2. Here, we characterize a related human protein containing MA3- and W2-type HEAT domains, previously termed BZW2 and renamed here as eIF5-mimic protein 1 (5MP1). Human 5MP1 interacts with eIF2 and eIF3 and inhibits general and gene-specific translation in mammalian systems. We further test whether 5MP1 is a mimic or competitor of the GEF catalytic subunit eIF2B epsilon or eIF5, using yeast as a model. Our results suggest that 5MP1 interacts with yeast eIF2 and promotes TC formation, but inhibits TC binding to the ribosome. Moreover, 5MP1 is not a GEF but a weak GDI for yeast eIF2. We propose that 5MP1 is a partial mimic and competitor of eIF5, interfering with the key steps by which eIF5 regulates eIF2 function.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据